Home/Filings/4/A/0001493152-24-010787
4/A//SEC Filing

Karkus Ted William 4/A

Accession 0001493152-24-010787

CIK 0000868278other

Filed

Mar 20, 8:00 PM ET

Accepted

Mar 21, 4:30 PM ET

Size

6.0 KB

Accession

0001493152-24-010787

Insider Transaction Report

Form 4/AAmended
Period: 2024-03-17
Transactions
  • Award

    Option (right to buy)

    2024-03-17+400,000400,000 total
    Exercise: $6.00Exp: 2031-03-17Common Stock (400,000 underlying)
Footnotes (2)
  • [F1]Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on the grant date and the remainder vesting and becoming exercisable in equal annual installments on the first, second and third anniversaries of the grant date.
  • [F2]This amended report on Form 4 is being filed to correct the information in Table II, Box 5 as the share amount was inadvertently reported under the wrong subheading in the original Form 4 filed on March 19, 2024.

Documents

1 file

Issuer

ProPhase Labs, Inc.

CIK 0000868278

Entity typeother

Related Parties

1
  • filerCIK 0001457896

Filing Metadata

Form type
4/A
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:30 PM ET
Size
6.0 KB